Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 3

Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome

Total article views   Abstract views HTML views PDF downloads Totals
11,923 Dovepress* 8,708 707+ 2,609 9,415
PubMed Central* 6 2,502 841 2,508
Totals 8,714 3,209 3,450 11,923
*Since 24 May 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 0 4

View citations on PubMed Central and Google Scholar